[La Peyronie disease, erectile dysfunction, kidney tumors]]

MeSH terms

• Adult
• Age Factors
• Anti-Inflammatory Agents / administration & dosage
• Anti-Inflammatory Agents / therapeutic use
• Biopsy
• Erectile Dysfunction* / drug therapy
• Erectile Dysfunction* / epidemiology
• Follow-Up Studies
• Humans
• Hydrocortisone / administration & dosage
• Hydrocortisone / therapeutic use
• Kidney / pathology
• Kidney Neoplasms* / mortality
• Kidney Neoplasms* / pathology
• Kidney Neoplasms* / surgery
• Male
• Middle Aged
• Nephrectomy
• Penile Induration* / diagnosis
• Penile Induration* / drug therapy
• Penile Induration* / surgery
• Phosphodiesterase Inhibitors / administration & dosage
• Phosphodiesterase Inhibitors / therapeutic use
• Piperazines / administration & dosage
• Piperazines / therapeutic use
• Purines / administration & dosage
• Purines / therapeutic use
• Sildenafil Citrate
• Sulfones / administration & dosage
• Sulfones / therapeutic use
• Time Factors
• Treatment Outcome
• Vasodilator Agents / administration & dosage
• Vasodilator Agents / therapeutic use
• Verapamil / administration & dosage
• Verapamil / therapeutic use